Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    11-n-0204
Show Display Options
Rank Status Study
1 Withdrawn Bevacizumab With or Without Surgery for Adult Glioblastomas
Conditions: Glioblastoma;   Brain Neoplasm
Intervention: Procedure: Craniotomy
2 Completed PET Brain and Whole Body Distribution Studies for Nociceptin/Orphanin FQ Peptide (NOP) Receptor Using [11C]NOP-1A
Conditions: Pain;   Anxiety;   Depression
Intervention: Drug: NOP-1A
3 Completed A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Condition: Diabetic Nephropathies
Interventions: Drug: PF-00489791;   Drug: Placebo
4 Completed GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults
Condition: Sepsis
Interventions: Drug: Intravenous GR270773- Phospholipid Emulsion;   Other: Placebo
5 Terminated Evaluation of Weekly Subcutaneous Biotinylated Idraparinux Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: Idrabiotaparinux;   Drug: Warfarin;   Drug: Placebo (for idrabiotaparinux);   Drug: Placebo (for warfarin);   Drug: Avidin;   Drug: Placebo (for avidin)

Indicates status has not been verified in more than two years